Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionHMS Capital Management, LLC
Latest Disclosed Ownership497 shares
Latest Disclosed Value $ 221,930
HMS Capital Management, LLC ownership in VRTX / Vertex Pharmaceuticals Incorporated

On April 22, 2026 - HMS Capital Management, LLC filed a 13F-HR form disclosing ownership of 497 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $221,930 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 16, 2026 disclosing 497 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 0.00% during the quarter. The current value of the position is $219,545 USD.

HMS Capital Management, LLC has a history of taking positions in derivatives of the underlying security (VRTX) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

VRTX / Vertex Pharmaceuticals Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-22 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 497 0 0.00 222 -1.78 0.0696
2026-01-16 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 497 -448 -47.41 225 -39.19 0.0932
2025-10-30 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 945 -3 -0.32 370 -12.32 0.1556
2025-07-07 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 948 -122 -11.40 422 -16.77 0.1897
2025-05-14 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,070 473 79.23 508 111.25 0.2816
2025-01-29 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 597 0 0.00 240 -13.36 0.1162
2024-10-30 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 597 0 0.00 278 -0.72 0.1361
2024-07-24 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 597 0 0.00 280 12.05 0.1458
2024-04-24 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 597 0 0.00 250 2.89 0.1382
2024-01-17 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 597 0 0.00 243 16.91 0.1493
2023-10-19 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 597 0 0.00 208 -1.43 0.1374
2023-08-14 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 597 -155 -20.61 210 -11.02 0.1276
2023-04-13 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 752 0 0.00 237 8.76 0.1492
2023-01-23 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 752 -20 -2.59 217 -3.12 0.1243
2022-10-12 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 772 0 0.00 224 2.75 0.1359
2022-07-27 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 772 772 218 0.1095
2021-11-02 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -1,270 -100.00 0 -100.00
2021-07-13 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,270 0 0.00 256 -6.23 0.1151
2021-04-12 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,270 0 0.00 273 -9.00 0.1156
2021-01-29 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,270 -4,294 -77.17 300 -80.18 0.1364
2020-10-20 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 5,564 -326 -5.53 1,514 -11.46 0.5877
2020-07-31 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 5,890 4,888 487.82 1,710 618.49 0.7519
2020-04-27 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,002 0 0.00 238 8.68 0.2318
2020-01-29 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,002 1,002 219 0.0922
2019-10-15 2019-09-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 0 -1,002 -100.00 0 -100.00
2019-07-12 2019-06-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 1,002 1,002 184 0.0794
2019-04-24 2019-03-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 0 -2,482 -100.00 0 -100.00
2019-01-14 2018-12-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 2,482 0 0.00 411 -14.02 0.2070
2018-11-02 2018-09-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 2,482 0 0.00 478 13.27 0.2370
2018-08-06 2018-06-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 2,482 2,482 422 0.2388
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-01-29 2020-12-31 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-10-20 2020-09-30 13F VERTEX PHARMACEUTICALS COM Put 1,900 0.00 517 -6.34 n/a n/a n/a
2020-07-31 2020-06-30 13F VERTEX PHARMACEUTICALS COM Put 1,900 552 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.